pharma news

News

Bottle of Tavneos with two pills in front of it

EMA looks into 'data integrity' issue with Amgen's Tavneos

Concerns about efficacy data in the main trial behind the approvals of Amgen and CSL Vifor's Tavneos have triggered a review in the EU.

News

FDA starts review of Summit's VEGFxPD-1 bispecific

Summit moves ahead in the race to bring a VEGFxPD-(L)1 drug to market, after the FDA started a review of ivonescimab in lung cancer.

News

Three more biotechs price their Nasdaq IPOs

AgomAb, SpyGlass, and Veradermics have all set the terms for their IPOs this week, looking to raise somewhere between around $150m and $200m.

News

Man with measuring tape around his torso

GLP-1 drugs linked to pancreatitis, gallbladder problems

Users of weight-loss therapies based on GLP-1 agonists have been warned to be aware of a rare complication, pancreatitis, that can be severe.

News

AZ deepens Chinese ties, signs $18.5bn CSPC obesity deal

AstraZeneca deepens ties with China, pledging $15bn in investment and signing a big $18.5bn alliance with CSPC Pharma for obesity and diabetes drugs.

News

Tenpoint eyes presbyopia drug launch after FDA nod

Tenpoint is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis, and LENZ with a dual-acting rival.

EMA looks into 'data integrity' issue with Amgen's Tavneos

FDA starts review of Summit's VEGFxPD-1 bispecific

Three more biotechs price their Nasdaq IPOs

GLP-1 drugs linked to pancreatitis, gallbladder problems

AZ deepens Chinese ties, signs $18.5bn CSPC obesity deal

Tenpoint eyes presbyopia drug launch after FDA nod

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

pharma news

Editor's Picks